Eleni Lagkadinou - BioNTech SE, Mainz, Germany

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 38 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Facts and Hopes on Biomarkers for Successful Early Clinical Immunotherapy Trials: Innovative Patient Enrichment Strategies

Michael A. Cannarile,Vaios Karanikas,Bernhard Reis,Christoph Mancao,Eleni Lagkadinou,Dominik Ruettinger,Natascha Rieder,Franclim R. Ribeiro,Henry Kao,Sebastian Dziadek,Bruno Gomes

CLINICAL CANCER RESEARCHno. 8 (2024): 1448-1456

Cited0Views0WOSBibtex

Supplementary Figure from Preclinical Characterization and Phase I Trial Results of a Bispecific Antibody Targeting PD-L1 and 4-1BB (GEN1046) in Patients with Advanced Refractory Solid Tumors

openalex（2023）

Cited0Views0Bibtex

Supplementary Figure from Preclinical Characterization and Phase I Trial Results of a Bispecific Antibody Targeting PD-L1 and 4-1BB (GEN1046) in Patients with Advanced Refractory Solid Tumors

openalex（2023）

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn